An order prohibiting six local companies—Natco Pharma, Hetero, BDR Pharma, Shilpa Medicare, Alkem, and Laurus Labs—from marketing generic versions was recently passed by the Delhi High Court.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback